Thursday, 25th August Australian Diabetes Society and the Australian Diabetes Educators Association Annual Scientific Meeting 2016

• Effects of Antecedent Hypoglycaemia on the Gastric and Cardiac Responses to Subsequent Hypoglycaemia in Health - Palash Kar
• Evaluation of Closed Loop Performance in Adults with Type 1 Diabetes Undertaking Anaerobic Versus Aerobic Exercise: A Randomised Crossover Study - Dilshani Jayawardene
• Predictors of vision loss in type 2 diabetes mellitus: The Fremantle Diabetes Study Phase II - Jocelyn J Drinkwater
• Maternal characteristics and perinatal outcomes of Aboriginal and Europid women with gestational diabetes and diabetes in pregnancy: The PANDORA Study - I-Lynn Lee
• Pulmonary microvascular disease in diabetes mellitus (DM) subjects detected by exercise echocardiography is not associated with reduced exercise capacity - Timothy J Roberts
• Use of a glucose alert pathway and connectivity blood glucose meters reduces inattention to hospital diabetes management - Mervyn Kyi
• Glycaemic variability in Type 1 diabetes patients is better with continuous subcutaneous insulin infusion (CSII) therapy than with multiple daily injection (MDI) treatment. - Emma Scott
• Associations between age, age at diagnosis and diabetes duration with vascular events in type 2 diabetes - Natalie Nanayakkara

• Investigating the molecular basis and therapeutic potential of the HO-1 adiponectin axis - Johanna L Barclay
• Hot and Sweet: Human brown fat beyond thermoregulation - Paul Lee
• Obesity-induced adipose tissue macrophages: culprits or construction workers? - Mark A Febbraio
• Diabetes, Obesity and the Central Role of the Adipocyte in Maintaining Systemic Lipid Homeostasis - Philipp E Scherer

• MicroRNAs of human insulin producing cells in pancreas, gallbladder and brain - Wilson Wong
• Pancreatic transdiffereniation of human and mouse hepatocytes in FRG mice - Ann M Simpson
• High fat fed NOD.B10 foz/foz mice have a type 2 diabetes phenotype without evidence of islet beta-cell dysfunction in vitro - Viviane Delghingaro-Augusto
• Overexpression of the Unfolded Protein Response Gene Herpud1 leads to impaired insulin secretion but protection from high fat induced glucose intolerance - Amy Huang
• PTPN1, a novel target for limiting interferon signalling in β-cells to protect against autoimmune diabetes - William J Stanley
• Deletion of PKCε in macrophages improves beta cell function - Liam J O'Reilly
• Hypoxia inducible factor-1α (HIF-1α) is required for β-cell survival in Type 1 diabetes (T1D) caused by immunological insults - Amit Lalwani
• Autophagy plays a role in regulation of glucose-stimulated insulin secretion in pancreatic beta-cells under different nutrient conditions - Kwan Yi (Connie) Chu

Speakers: Natalie Raffoul, Anthony Russell, Gary Deed & Michelle Robins

This workshop will facilitate a case-based peer discussion focussing on glucose management of type 2 diabetes in the context of the updated Australian Diabetes Society (ADS) treatment algorithm. Discussion of the cases will explore factors influencing the choice of second and third-line blood glucose lowering medicines, the stepwise treatment of diabetes and determining when to escalate therapy as well as identifying the best approach to assess, manage and monitor risk of diabetes complications.

Learning objectives:

• Explore the factors influencing the choice of blood glucose lowering therapies for type 2 diabetes and determine when to escalate therapy
• Identify strategies to promote medication adherence
• Develop a systematic approach to assess, manage and monitor risk of diabetes complications.
• Individualise glycaemic treatment targets depending on patient specific factors

Intended audience: Mixed health professionals, particularly GPs, nurses and allied health workers.

Aim and learning objectives:

The aim of this 2 hour symposium is to canvas recent evidence from Australia and the UK about effective strategies and promising interventions to support timely treatment intensification to achieve glycaemic targets for people with T2D in primary care.
The seminar is aimed at practicing RN-CDEs.

Overview:

Professor Kamlesh Khunti (via Skype) - Clinical inertia in primary care for T2D: extent of the problem, reasons and possible solutions
This presentation will draw on systematic and targeted reviews in progress.

John Furler - The Stepping Up Study: A practice based innovation to overcome clinical inertia in primary care insulin initiation
This presentation will present results of a randomised trial of a Practice Nurse-led model of care in Australian primary care for supporting treatment intensification in people with T2D.

Elizabeth Holmes-Truscott - The psychosocial context of treatment intensification: Barriers to early insulin initiation – Perspectives of individuals living with T2DM
This presentation will drawing on data analysis of the Diabetes MILES (Management and Impact for Long-term Empowerment and Success) study, as well as baseline data analysis from the Stepping Up study with a focus on predictors of insulin resistance versus insulin willingness. This presentation will highlight potential opportunities for CDEs to use this evidence in their practice to support people with T2D.

Jo-Anne Manski-Nankervis - The inter-professional context of treatment intensification: Barriers to early insulin initiation – Health professional perspective
This presentation will draw on analysis of qualitative and health professional survey data (including items drawn from the Diabetes Attitudes, Wishes and Needs study) from within the Stepping Up Study. Again this presentation will highlight potential opportunities for CDEs to use this evidence in their practice to support GPs and Practice Nurses working with people with T2D.

Panel discussion - Future directions for a primary care based treatment intensification. How does this work translate to current usual practice?

Learning Outcome:

• Increased knowledge of the barriers and opportunities to optimise treatment intensification for people with T2D out of glycaemic targets in primary care

• Overcoming clinical inertia in glycaemic therapy for T2D in primary care: Theory & practice - John Furler, Elizabeth Holmes-Truscott, Jo-Anne Manski-Nankervis and Kamlesh Khunti

(Morning tea provided)

Aim:

The aim of the interactive workshop is to engage with and challenge participants to:

• Identify risks for older people with diabetes (OPWD) when transitioning to, between and from care settings: acute, community, respite, rehabilitation and community.
• Develop strategies to engage with OPWD and the care team to proactively plan to minimise transitional risks using a Diabetes-Specific Discharge Planning Tool for Older People with Diabetes.

Overiew:

Ms Michelle Robins - Introduction and outline of the workshop

Ms Nicole Duggan - Diabetes, discharge planning and engaging with older people: whose role is it? 

Professor Trisha Dunning - Identifying transitional risks for older people with diabetes - a proactive preventative approach

Dr Sally Savage - Developing a Personalised Discharge Planning Tool for Older People with Diabetes  

Ms Bernadette Unmack - Introduction to case studies

Ms Michelle Robins - Group Discussion and Case Studies

Q&A

Ms Nicole Duggan - Resources to support health professionals  

Ms Michelle Robins - Summary of key points and close

Learning objectives: 

At the end of the workshop participants will be able to:

• Determine diabetes-specific and other factors that trigger an acute admission or readmission for older people with diabetes.
• Identify how to engage with older people with diabetes and their family carers and health professionals to identify and minimise risks associated with care transitions at discharge.  
• Examine the diabetes educators (community/outpatient/acute/subacute) role and responsibility in discharge planning for older people with diabetes.
• Contribute to safe discharge planning for older people with diabetes and family members.

• Diabetes-Specific Discharge Planning for Older People with Diabetes.  - Nicole Duggan, Trisha Dunning, Sally Savage and Bernadette Unmack

*NB: The entrance to Central Room B is via the Exhibition Hall

If you wish to attend this workshop, please ensure you arrive on time as places are limited

Aim:

To examine the intricacies of carbohydrate counting from a dietary perspective in order to gain a better understand of the day-to-day practical challenges.

Overview:

1. What is carb counting?
   - Australian Dietary Guidelines
   - Avoiding carb centric diets
   - What are Australians currently eating?
   
   
2. Why do we carb count? 
   - Why do we recommend carb counting and what is the evidence and current guidelines
   
   
3. Who?
   - Roles of different dibetes health professionals in particular the role of the CDE in supporting carb counting
   - Special populations and carb counting (eg: paediatrics)
   
   
4. How to carb count
   - The practical considerations for carb counting
   - Basic skills in carb counting
   - Resources for carb counting (writen, apps, meters)
   Barriers to carb counting in different group and how to overcome these using practical tips
   
   
5. Watch this space
   - Areas of current research that may affect carbohydrate counting in the future
   - Dosing for fat and protein
   
   
6. Q&A

Learning Outcomes/ Objectives:

• Identify and describe the factors affecting carbohydrate counting from a whole diet perspective
• Identify the effects of different dietary patterns on carbohydrate counting
• Discuss the importance of diet quality in addition to carbohydrate counting
• Understand the challenges of carbohydrate counting

• More than just the carbs - a new look at carbohydrate counting  - Alison Bennett and Kathryn Kirchner

*NB: The entrance to Central Room B is via the Exhibition Hall

If you wish to attend this masterclass, please ensure you arrive on time as places are limited

Aim:

The aim of this symposium is to highlight recent research findings and emerging thinking regarding the psychological aspects of living with diabetes, with a particular focus on preventing and managing long-term complications.

Overview:

The 2-hour seminar will include; 

• 5 x 20 minute presentations
• 1 x 20 minute panel discussion facilitated by symposium co-chair Ann Morris

Dr Jessica Browne - How big? Social stigma among adults with diabetes and its implications for diabetes self-management

Dr Gwyneth Rees - Visualising complications: lessons from a randomised trial of personalised eye consultations

Prof Jane Speight - Avoiding problematic hypoglycaemia: rethinking our focus on the long-term complications

Prof Helen Murphy - A psycho-technological approach to preventing adverse outcomes in pregnancy

Prof Timothy Skinner - Diabetes distress and depression: can we prevent them?

Panel Discussion

Learning objectives:

• Learn about the findings of recent seminal studies
• Acquire a psychological perspective on the development and management of diabetes-related complications
• Learn what health professionals can do to support people with diabetes in preventing (or preventing progression of) complications

This symposium will be of interest to diabetes educators, endocrinologists, GPs, psychologists and other clinicians / researchers working in the field of diabetes.

• Novel and emerging psychological issues in preventing and managing diabetes-related complications - Jane Speight, Jessica Browne, Gwyneth Rees, Helen Murphy and Timothy Skinner

• Functional Magnetic Resonance Imaging (MRI) changes in Type 1 Diabetes with and without Renal Hyperfiltration - Jas-mine Seah
• Sulfonylurea therapy, hypoglycaemia, glycaemic variability and changes in ventricular repolarisation - Timothy Middleton
• Metformin usage in adults with type 1 diabetes in the Australian National Diabetes Information Audit and Benchmarking (ANDIAB) Initiative - Angela S Lee
• Psychosocial factors in patients presenting with diabetic ketoacidosis - Azni Abdul-Wahab
• Meta-analysis of the outcomes of twin pregnancies complicated by gestational diabetes mellitus - Sarah Glastras
• Is hearing impairment another diabetes complication? - Akhil Gupta
• Reversal of Type 2 Diabetes in Youth who adhere to a Very Low Energy Diet; the SHAKE IT pilot study - Megan L Gow

• Metabolic effect of high-calorie meals on type 1 diabetic individuals with and without nephropathy (The FinnDiane Study) - Stefan Mutter
• Beta-cell function interpolated from fasting plasma C-peptide is a robust marker of disease progression and response to immune therapy in children and young adults with type 1 diabetes. - John M Wentworth
• Suboptimal overnight glucose control behaviours common in adults with Type 1 diabetes: An assessment tool and need for education. - Alicia J Jenkins
• High rates of obesity in young adults with type 1 diabetes (T1D) - Christopher Rowe
• Investigation of cardiac biomarkers in ambulatory type 1 diabetes patients - Han Ling H.L Fam
• HbA1c and other cardiovascular risk factors: outcomes in a tertiary multidisciplinary Young Adults Diabetes Service - Annie Hung
• Clinical characteristics in adult vs juvenile-onset type 1 diabetes - Shanal Kumar
• Brittle Diabetes: Time to Break a Delicate Diagnosis? - Jennifer Snaith

• A comparison of GP and specialist diabetes clinic based adult Type 1 diabetes glucose self-care and control. - Gary Kilov
• Insulin pump therapy practices in young adults with type 1 diabetes in a tertiary hospital young adults transition clinic - Thora Y Chai
• Management of eating disorders in type 1 diabetes - Stephanie Teasdale
• Managing lipids in Type 1 Diabetes (T1D) – how are we doing? - Anna Galligan

• Euglycaemic DKA in a patient with LADA after treatment with empagliflozin. - Nishant Nundlall

• Intermittent Fasting: appears an effective and safe strategy for weight loss and metabolic control in Type 2 Diabetes - Charmaine Griffiths
• Effect of blueberry tea on improving metabolic and vascular function in people with type 2 diabetes - A Pilot Study - Donghua Hu
• Vitamin D is associated with adiposity and cardiometabolic risk factors in a predominantly vitamin D-deficient and overweight/obese but otherwise healthy cohort - Aya Mousa
• Mixed Meal Testing: Effective Clinical Tool or Outdated Investigation? - Stephanie Bond

• Early weight loss responders to liraglutide 3.0 mg had greater weight loss, regression to normoglycaemia, and reduced T2D development at 3 years vs early non-responders: SCALE Obesity and Prediabetes - Samantha Hocking
• Characteristics of individuals developing type 2 diabetes in the SCALE Obesity and Prediabetes randomised, double-blind, liraglutide vs placebo trial - Samantha Hocking
• Weight loss and associated improvements in cardiometabolic risk factors with liraglutide 3.0 mg in the SCALE Obesity and Prediabetes randomised, double-blind, placebo-controlled 3-year trial - Trisha O'Moore-Sullivan
• Gastric band surgery for overweight but not obese people is a cost-effective treatment for type 2 diabetes - John Wentworth
• Salicylates intervention improves several cardiometabolic outcomes: meta-analysis of RCTs - Estifanos Baye
• Improvement in IWQOL-Lite-derived health utility score with liraglutide 3.0 mg versus placebo over 3 years in prediabetes - Gary Kilov

• Diabetes distress and depression in type 2 diabetes: The Fremantle Diabetes Study Phase II - Christine Underwood
• Young onset type 2 diabetes: Out of Touch and Out of Time - Charmaine Griffiths
• Sydney Samoan Community perspectives on the diabetes epidemic - Annalise T Vaovasa
• Are the diagnoses of diabetes and sarcopenia associated with patients' progress in inpatient rehabilitation? A systematic literature review - Irina Churilov

• Age of diabetes onset: glycaemic control and hypoglycaemia benefit with new insulin glargine 300 U/mL in T2DM - Stephen Twigg
• Switching from twice-daily basal insulin to once-daily new insulin glargine 300 U/mL (Gla-300): an analysis in people with T2DM (EDITION 1 and 2) - Michael d'Emden
• Real-world experience with Dapagliflozin in people with type-2 diabetes living in Western Sydney: Beneficial impact on biomarkers and reasons for discontinuation. - Tristan Nguyen
• A one-year prospective experience using Optifast^® vs glucagon-like peptide-1 analogues in obese adult patients with type 2 diabetes - Ramy H Bishay
• Effect of exenatide in combination with insulin in patients with type 2 diabetes mellitus on insulin requirement, weight and glycaemic control – prospective audit on local clinical protocol (follow-up result) - Ning Ning Choo
• Response to exenatide over 2 years in very obese type 2 diabetics. - Richard Burnet
• Decreased stomal output in response to liraglutide: a case study - Yee -Ming Melody YM Cheung
• Factors associated with insulin-induced weight gain in an Australian type 2 diabetes outpatient clinic. - John M Wentworth
• Prescription of hypoglycaemic medications in people with renal impairment and type 2 diabetes attending Australian general practice - Jo-Anne E Manski-Nankervis
• Improving the Transition of Care of Inpatients with Type 2 Diabetes - Felicity Pyrlis
• Fournier’s syndrome: a life threatening complication of SGLT2 inhibition in poorly controlled diabetes mellitus - Wenlin Cecilia Chi
• The changing management of type 2 diabetes - metabolic/bariatric surgery in Western Sydney - Carolyn Jameson
• Efficacy of an intensive and integrated team-based model of care for severely obese patients with type 2 diabetes in a public hospital setting   - Evan Atlantis
• Factors Associated with Insulin Adherence among Patients with Type 2 Diabetes: The MOSAIc Study - Helen Barraclough
• Silent Diabetic Ketoacidosis: Sodium-Glucose Cotransporter 2 Inhibitor-Induced Euglycaemic Diabetic Ketoacidosis - Shamil D Cooray

• Elderly Patients with Type 2 Diabetes Mellitus: Role of HbA1c as predictor of hypoglycaemia? - Jane Cummack
• Diabetes in the Elderly - Dahlia Davidoff

• Time series modelling to forecast prehospital Emergency Medical Service demand for diabetic emergencies - Melanie Villani
• The role of paternal factors in young onset type 2 diabetes (YT2DM) - Belinda Brooks
• A Poll to determine ethnic differences of diabetes in Australia - Margaret McGill
• Observational study of Diabetic Ketoacidosis admissions at two tertiary hospital sites in Western Australia from 2008-2010. - Kyaw Thura
• Early admission glycaemia predicts glycaemic extremes in hospitalised patients with diabetes - Mervyn Kyi
• Identification of novel plasma biomarkers of rapid eGFR decline in type 2 diabetes. - Kirsten E Peters
• An inpatient audit of diabetes in an Australian tertiary hospital utilising the UK National Diabetes Inpatient Audit tool. - Jack Lockett
• Predictive value of serum testosterone for type 2 diabetes risk assessment in men - Evan Atlantis
• Diabetes and its risk factors in a Samoan community. - Annalise Vaovasa
• Healthcare Use and Expenditure for Diabetes in Bangladesh - Shariful Islam
• An Audit of the Cardio-Metabolic risk profile of adults attending a tertiary referral hospital Diabetes Clinic in South Western Sydney. - Sarah N Parry
• A Hospital snapshot of Obesity and Type 2 Diabetes - Ashley Mr Sandison
• Factors associated with glycaemic control among patients with type 2 diabetes attending diabetes centres: Results from ANDA 2015 - Natalie Nanayakkara
• The Impact of Diabetes on Health Related Quality of Life: Results from a Case Control Study in Bangladesh - Shariful Islam

• The impact of moderate-intensity continuous and high-intensity interval training on plasma miRNA profile of hyperglycaemic patients - Alba Moreno-Asso
• Diabetes in hospitalised patients; a whole of hospital single day evaluation. - Gerry Fegan
• Diabetes and Urbanisation in Papua New Guinea: A Call to Action - Usman Malabu
• Chest radiography – An over-utilised investigation in diabetic ketoacidosis? - Chau Thien Tay
• Co-existence of Arthritis in Type 2 Diabetic Patients Alters the liver Enzyme and lipid Biomarkers - Afrin Jahan
• Does diabetes influence a person’s functional independence whilst in hospital? - Jacqueline Kay
• The Aboriginal Health Practitioner Diabetes Mentoring Pilot Study - Coralie E Cross

• Prevalence of Diabetes Before and After Lung Transplantation - Michael Reyes

• Hypoglycaemia: Prevalence and characterisitics in non-diabetic adults with Cystic Fibrosis, attending a centre in Australia - Monica Wagenaar
• Novel CFTR modifiers may rapidly restore β-cell function in patients with cystic fibrosis - Jeff Ahn

• Pembrolizumab Induced Diabetes – A Case Series - Anna Galligan
• Challenges in the Management of Rociletinib-Induced Hyperglycaemia - Shan Jiang
• A Retrospective Audit of Pancreatectomy Surgery and Diabetes - Shamendri Dasssanayake
• The management of unstable diabetes in a cancer population – a retrospective audit - Sarah Qian

• The Effect of the Patient-Physician Relationship on Insulin Progression, Diabetes Distress, Adherence, and HbA1c Control over Time: Insights from the MOSAIc Study - Helen Barraclough
• DATABETES: introducing online psychosocial research participation and service evaluation in a community centre for children with type 1 and their families - Lisa Robins
• Improved mental health in diabetes: are we there yet? - Gemma Macdonald
• Diabetic ketoacidosis and severe hypertriglyceridemia as a consequence of an atypical antipsychotic agent - Malgorzata Brzozowska
• Awareness, knowledge and attitudes on diabetes mellitus of Sri Lankan patient population attending a Colombo suburb Hospital. - Waranga Jayawickrama
• Preventing Diabetes in people with Depression in primary health care (PDD trial): a pilot study - Evan Atlantis

• Gaining clinical experience using continuous glucose monitoring system (CGM) in people with type 2 diabetes mellitus (T2DM) - Amy N H Nguyen
• Frequency of and reasons for self-monitoring of blood glucose among Australians with insulin-treated diabetes. Results from the YourSAY: Glucose Monitoring study - Elizabeth Holmes-Truscott
• Cost Effectiveness of FreeStyle Libre® Flash Glucose Monitoring System from an Australian Health Care Payer Perspective - Matt Kirchmann
• Smartphone Application for Self Blood Glucose Monitoring & Disease Management- A Case Report - Marcos Medina
• The use of continuous blood glucose monitoring in adults with type 1 diabetes mellitus  - Chee Tang
• Accu-Chek Blood Glucose Monitoring System Global Strip Handling Study - Stacy Davis

• Low glucose level on glucose tolerance test during pregnancy: do we need to worry? - Sara Bontempo
• Younger age at conception adversely affects outcomes of pregnancy in young women aged 16-25 with type I diabetes (T1D) - Jane Holmes-Walker
• First trimester screening for gestational diabetes: A risk prediction model combining maternal clinical and biomarker parameters      - Arianne N Sweeting
• Higher maternal serum prolactin levels are associated with reduced glucose tolerance during pregnancy - Niloufar Torkamani
• Pregnant women should be risk-stratified to prevent unnecessary glucose challenge - Evelyn Tan
• Adherence to guideline-based early testing for gestational diabetes in a Victorian tertiary centre - Lik-Hui W Lau
• Maternal Characteristics and Perinatal Outcomes for Women Treated with Metformin in Gestational Diabetes - Sarah Glastras
• Effects of Metformin Exposure during Pregnancy on the Epigenome - Mugdha Joglekar
• Women After Gestational Diabetes (WAGs) pilot program: Engaging women in a lifestyle modification program post gestational diabetes. - Monique Vero

• The Effect Of Salt Versus Placebo Supplementation On Haematocrit Levels In Type Two Diabetes Mellitus - Adrian Michalopoulos
• Gain and Loss Framing of Complications Messages in Diabetes-specific Media - Linda J Beeney

• Prevalence and independent factors associated with diabetes-related and non-diabetes-related foot ulcers in a representative inpatient population - Peter Lazzarini
• Defining the utility of clinical vascular testing to identify those with diabetic foot complications - Vivienne H Chuter
• High Rate of Diabetes Lower Limb Amputation in Indigenous Australians: Is There a Causal Factor? - Usman H. Malabu
• Observational study of admissions to the inpatient Multidisciplinary Diabetic Foot Unit at Fiona Stanley Hospital: experiences from the first year of operation - Lydia Lamb
• Clinical Associations  Across a Spectrum of Ankle Brachial Index Readings in Patients with Diabetes Mellitus - Tamara K Young
• Diabetes-related major lower limb amputation in rural and Indigenous Western Australians – Missed opportunities for earlier intervention? - Aminath Laafira
• Telemedicine: Harnessing Technology to Manage Diabetic Foot Ulcers in Rural Areas -a systematic review - Tejas Pratap Singh
• Micro- and neurovascular complications in type 2 diabetes mellitus - the prevalence and potential risk factors - Jaap J van Netten
• Mechanical noise improves the vibration perception threshold of the foot in people with diabetic neuropathy - Jaap J. van Netten
• Excoriation (skin-picking) disorder in a patient with Double Diabetes leading to multiple finger amputations - Alice Hong
• Modern Pedorthics saves limbs and keeps you on your toes. - Ernie Tye
• Relationships among neuropathies, vascular reactivity and bone in the diabetic foot - Alex Barwick
• Effects of GLP-1 Agonism on Peripheral Nerve Function in Type 2 Diabetes - Tushar Issar
• Peripheral Neuropathy in the Hands of People with Diabetes Mellitus - Samantha L. Ennis

• Co-designing an integrated patient-centred health service for co-morbid diabetes and chronic kidney disease. - Clement Lo
• A systematic review investigating the incidence of chronic kidney disease in diabetes - Digsu Koye
• Management of Diabetes Mellitus in Inpatients with Chronic Diabetic Kidney Disease - Jasper Sung
• A Diabeto‘genic’ Syndrome: HNF1B mutation and a severe case of anuric renal failure causing perinatal mortality - Wenlin Cecilia Chi

• Health-worker led Retinal Imaging, Diabetes-related Eye Health Education and Lifestyle Survey Administration as a Model for Diabetic Retinopathy Screening in Indigenous Australians with Diabetes - Laima Brazionis

• Prevalence and treatment of metabolic pattern dyslipidaemia (MPD) in patients with established coronary disease – an Australian outpatient study - Geoffrey Holt
• Standard of in-patient hyperglycaemia management in patients with acute ischemic stroke and the impact of standardised insulin chart, on delivery of care in these patients. - Danish S Mahmud

• Specialised Physiotherapy for in-patients with Diabetes leads to improved outcomes - Jacqueline Kay
• Case-conference style consultations in GP practices with Specialist and Primary care teams: an efficient way to improve diabetes outcomes for our population - Shamasunder Acharya
• Comparison of management of in-patient hyperglycaemia by standard specialist care vs basal-bolus-booster insulin in a tertiary referral hospital - Lili Yuen
• Patient and Healthcare Provider Attitudes Towards Insulin Therapy in a Tertiary Referral Hospital in South West Sydney - Jessica Lai
• Impact of the NSW Adult Subcutaneous insulin prescribing chart on glucose management at the John Hunter Hospital, Newcastle - Ushank P Ranasinghe
• Diabetes related medication errors:  An analysis of Nepean Blue Mountains LHD IIMS report - Bradley Marney
• Postprandial hyperglycaemia and diabetes management - David Ali
• Integrated Care Pathway (ICP) for Discharge Preparation of Patients with Diabetes (PWD) - Claire C O'Brien
• Developing a computer program that can assist GPs to choose antidiabetic medications in according to the Australian Diabetes Society Guidelines and Pharmaceutical Benefits Schemes. - Tri Tuyen Cao
• HbA1c reduction and engagement in an ambulatory insulin stabilisation program - Wayne J. Dawson

• High Fat Diets Induce Colonic Epithelial Cell Stress and Inflammation that is Reversed by IL-22 - Sahar Keshvari
• Identification and Characterization of Genes Associated With Hyperglycaemia and Reduced Insulin Secretion in Mice and Men - Chieh-Hsin Yang
• Genetic deletion of the Set7 lysine methyltransferase attenuates renal damage in a mouse model of diabetic nephropathy - Hanah Rodriguez
• Overexpression of Fructose Bisphosphatase 2 in muscle increases insulin-mediated glucose uptake.   - Ishita Bakshi
• Liver-Specific Deletion Of The Mitochondrial Stress Gene UBL-5 Leads To Liver Failure - Viktoria Ntouma
• Enhancing nuclear NAD⁺ via transgenic overexpression of the salvage enzyme NMNAT1 alters muscle fibre type and whole-body energy metabolism - Brenna Osborne
• Identifying the Role of Depot Specific Adipocyte Precursors in the Development of Obesity and Type 2 Diabetes - Arthe Raajendiran
• Il-1 signalling in macrophages is required for normal glucose homeostasis in the obese state - Phillippa T Whitworth

• Maternal lipoproteins and gut microbiome in early pregnancy - Helen L Barrett
• Evaluation of fasting blood glucose as an initial diagnostic test for gestational diabetes mellitus (GDM). - Michael d'Emden
• Gestational Diabetes – A reduction in neonatal hypoglycaemia with new diagnostic criteria and treatment targets - Lik-Hui W Lau
• Good4Mum: Delivering enhanced care to women with previous gestational diabetes in general practice - Sharleen L O'Reilly
• PCOS is characterised by a specific epigenetic signature in peripheral blood mononuclear cells: A pilot study - Danielle S Hiam
• Relationship between omega-3 polyunsaturated fatty acids and insulin resistance is sex-dependent: a systematic review and meta-analysis of randomized controlled trials - Kylie A Abbott
• The effect of exercise on visceral fat in type 2 diabetes. - Angelo Sabag
• Exercise capacity (VO_2max) is reduced in Type 2 diabetes mellitus (T2DM) but not Type 1 (T1DM), and is not due to diastolic dysfunction - Timothy J Roberts

• Challenges in the design and analysis of clinical trials - Arul Earnest
• The trials and tribulations of getting a drug to market - John Prins
• How systematic reviews can work for you: in practice and in research - Marie Misso
• Health economics: an introduction and overview - Danny Liew

Facilitators: Kate Marsh, Anne Marks, Nicole Duggan and Rachel Freeman

This year, the ADE Editorial Advisory Group will be facilitating an interactive and practical workshop ‘Writing for publication’ to assist novice authors to write for the ADE or other publications.

Bring along an idea for an article and our facilitators will help you get started in your journey to get published.  Participants will work in small groups along with a facilitator, to brainstorm ideas and discuss the best format for writing up their work. Gain input from colleagues and a member of the ADE Editorial team and leave with a documented outline for your article and an understanding of the steps to getting published.

In addition to feature articles covering a range of  topics relevant to diabetes education or management,  your articles could be based around an interesting or unusual case study, research you are doing in your workplace, teaching tips in the areas of your expertise, , a review of the literature in a particular area of diabetes education or reflection on an aspect of your current practice.

This is a not-to-be-missed session for those who are keen to get published but are not sure where to start.  Due to the interactive nature of the workshop, numbers will be limited so book your place now.

*Pre-Registration for this session is essential
*NB: The entrance to Central Room B is via the Exhibition Hall

Speaker: Rob Lockheart, Content Development & Delivery Manager, Strategic Brand and Planning Westpac

Understanding how your price, your costs and your time billed operate in your business is an important facet of a successful profitable business. In this 60 minute presentation Rob Lockhart Senior facilitator with Westpac’s Davidson Institute will take you through one of the simplest, most powerful tools in business, break even. You will understand; how to classify your costs and where to look for savings; the impact of price changes to your bottom line; and the impact of buying equipment on your business. Most importantly, Rob will take you through a step by step process to calculate your own break even

*NB: The entrance to Central Room B is via the Exhibition

If you wish to attend this workshop please ensure you arrive on time as places are limited